Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo - PubMed (original) (raw)

Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo

D L Willins et al. Neuroscience. 1999.

Abstract

In this study, we demonstrate that clozapine and other atypical antipsychotic drugs induce a paradoxical internalization of 5-hydroxytryptamine-2A receptors in vitro and a redistribution of 5-hydroxytryptamine-2A receptors in vivo. We discovered that clozapine, olanzapine, risperidone and the putative atypical antipsychotic drug MDL 100,907 all induced 5-hydroxytryptamine-2A receptor internalization in fibroblasts stably expressing the 5-hydroxytryptamine-2A receptor in vitro. Two 5-hydroxytryptamine-2A antagonists (mianserin and ritanserin), which have been demonstrated to reduce negative symptoms in schizophrenia, also caused 5-hydroxytryptamine-2A receptor internalization. Four different drugs, each devoid of 5-hydroxytryptamine-2A antagonist activity, had no effect on the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro. Treatment of rats for seven days with clozapine induced an increase in intracellular 5-hydroxytryptamine-2A receptor-like immunoreactivity in pyramidal neurons, while causing a decrease in labeling of apical dendrites in the medial prefrontal cortex. This redistribution of 5-hydroxytryptamine-2A receptors in pyramidal neurons was also seen when rats were chronically treated with another atypical antipsychotic drug, olanzapine. The typical antipsychotic drug haloperidol, however, did not induce a redistribution of 5-hydroxytryptamine-2A receptors in pyramidal neurons in the medial prefrontal cortex. Taken together, these results demonstrate that several atypical antipsychotic drugs with high 5-hydroxytryptamine-2A receptor affinities induce a redistribution of 5-hydroxytryptamine-2A receptors both in vivo and in vitro. It is conceivable that the loss of 5-hydroxytryptamine-2A receptors from the apical dendrites of pyramidal neurons is important for the beneficial effects of atypical antipsychotic drugs and other 5-hydroxytryptamine-2A antagonists in schizophrenia.

PubMed Disclaimer

Cited by

The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors.
Andressen KW, Manfra O, Brevik CH, Ulsund AH, Vanhoenacker P, Levy FO, Krobert KA. Andressen KW, et al. Br J Pharmacol. 2015 Aug;172(15):3846-60. doi: 10.1111/bph.13169. Epub 2015 Jun 12. Br J Pharmacol. 2015. PMID: 25884989 Free PMC article.
Pharmacological onomastics: what's in a name?
Kenakin TP. Kenakin TP. Br J Pharmacol. 2008 Feb;153(3):432-8. doi: 10.1038/sj.bjp.0707407. Epub 2007 Aug 13. Br J Pharmacol. 2008. PMID: 17700724 Free PMC article. Review.
Differential regulation of rat peripheral 5-HT(2A) and 5-HT(2B) receptor systems: influence of drug treatment.
Enguix MJ, Sánchez L, Villazón M, Brea J, Tristán H, Caruncho HJ, Cadavid MI, Loza MI. Enguix MJ, et al. Naunyn Schmiedebergs Arch Pharmacol. 2003 Aug;368(2):79-90. doi: 10.1007/s00210-003-0775-7. Epub 2003 Jul 12. Naunyn Schmiedebergs Arch Pharmacol. 2003. PMID: 12861437
Mu-opioid receptor redistribution in the locus coeruleus upon precipitation of withdrawal in opiate-dependent rats.
Scavone JL, Van Bockstaele EJ. Scavone JL, et al. Anat Rec (Hoboken). 2009 Mar;292(3):401-11. doi: 10.1002/ar.20860. Anat Rec (Hoboken). 2009. PMID: 19248160 Free PMC article.
Signalling bias in new drug discovery: detection, quantification and therapeutic impact.
Kenakin T, Christopoulos A. Kenakin T, et al. Nat Rev Drug Discov. 2013 Mar;12(3):205-16. doi: 10.1038/nrd3954. Epub 2012 Feb 15. Nat Rev Drug Discov. 2013. PMID: 23411724 Review.

Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo - PubMed (original) (raw)